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Cytogenetic analysis of peripheral blood lym-
phocytes (PBLs), a sensitive assay to detect
exposures to mutagens and carcinogens in
occupational settings, has been used in the
Czech Republic since 1975. Its validity at an
ecologic level has been confirmed by
numerous biomonitoring studies (1–10).
Cytogenetic analysis is a valuable tool widely
applied in the ﬁeld of occupational health in
the Czech Republic. Since 1975, several thou-
sand employees exposed to carcinogens,
mostly in chemical industries, have been
assayed, many of them repeatedly. This has
made it possible to assemble a retrospective
cohort large enough to carry out an epidemio-
logic study in which the major objective is to
test for an association between the frequency
of chromosomal aberrations (CAs) and a sub-
sequent risk of cancer. In spite of the extensive
use of the cytogenetic analysis in biomonitor-
ing of exposure on an ecologic level, the long-
term effects of an increased frequency of CAs
in individuals are still uncertain. 
Only a few epidemiologic studies have
attempted to address the problem of the pre-
dictive value of the CA assay in PBLs. A
modest increase in total cancer incidence
rate [incidence ratio = 2.08; 95% conﬁdence
interval (CI), 1.26–3.40] was observed in
individuals assigned to the high CA fre-
quency category in the Nordic cohort
(11–14). The results of the Italian cohort
(14–16) suggest an association between the
frequency of PBL CAs and cancer mortality
rates. In that case, the mortality ratio for
individuals with a high frequency of CAs in
PBLs was estimated to be 2.56 (95% CI,
1.35–4.86) for total cancer, 4.2 (95% CI,
1.14–4.38) for lung cancer, and 4.36 (95%
CI, 1.18–11.1) for cancers of lymphatic and
hematopoietic tissues (14–16). Also, in a
nested case–control study carried out in a
blackfoot endemic area, Liou et al. (17)
found a statistically significant association
between chromosome type-aberrations and
cancer. Kleinerman et al. (18) noted a corre-
lation between the CA frequency in PBLs
and cancer risk in women who received
different therapeutic doses of ionizing radia-
tion. Recently published outcomes of the
case–control study nested within the Nordic
and Italian cohorts conﬁrmed previous out-
comes; furthermore, Bonassi et al. (19) found
that the association between the CA fre-
quency and cancer did not appear to be mod-
iﬁed by sex, age, or time since the CA assay. 
Because better understanding of the
nature of the relationship of CA frequency
in PBLs to cancer risk is not only a scientiﬁc
issue but also a matter of public health con-
cern, we chose to discuss the results of ongo-
ing epidemiologic research in the Czech
Republic. Contrary to previously published
studies, in the Czech cohort, we could treat
the frequency of CAs as a continuous vari-
able. Furthermore, in addition to the vari-
ables such as age at cytogenetic analysis, time
since testing, and sex, we could control for
the type of occupational exposure. Finally, as
far as power considerations are of interest,
the present study is based on the largest study
population hitherto studied.
Methods
Study Population
The study base consists of individuals exam-
ined between May 1975 and October 1998
for the frequency of CAs in PBLs in four
cytogenetic laboratories (the Cytogenetic
Laboratory of the South Moravian Regional
Institute of Hygiene, the Cytogenetic
Laboratory of the North Bohemian Regional
Institute of Hygiene, the Cytogenetic
Laboratory of the Municipal Institute of
Hygiene at Brno, and the Cytogenetic
Laboratory of Institute of Hygiene of the
Capital, Prague). The subjects were selected
for cytogenetic analysis because of their
exposures to various occupational mutagens
and carcinogens.
Radon. The radon group consists of
underground miners exposed to radon gas in
one ore mine. Participants were examined for
the CA frequency in PBL in May 1975–
December 1990.
Radiation. The radiography ward group
consists of staff of the X-ray and radiothera-
peutic wards. Subjects were examined in
February 1989–August 1998.
Cytostatic drugs. The cytostatic drug
group consists of personnel exposed during
cytostatic drug production and medical
personnel who handled cytostatics. They
were examined in October 1981–October
1998.
Bis(chloromethyl) ether. The bis(chloro-
methyl) ether (BCME) group includes work-
ers exposed to BCME in one chemical plant.
Subjects were examined November 1975–
November 1987.
Coal gasiﬁcation. The coal gasiﬁcication
group is composed of workers who were
exposed to by-products of hard pressure coal
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We used cytogenetic analysis to carry out a cohort study in which the major objective was to test
the association between frequency of chromosomal aberrations and subsequent risk of cancer. In
spite of the extensive use of the cytogenetic analysis of human peripheral blood lymphocytes in
biomonitoring of exposure to various mutagens and carcinogens on an ecologic level, the long-term
effects of an increased frequency of chromosomal aberrations in individuals are still uncertain. Few
epidemiologic studies have addressed this issue, and a moderate risk of cancer in individuals with
an elevated frequency of chromosomal aberrations has been observed. In the present study, we ana-
lyzed data on 8,962 cytogenetic tests and 3,973 subjects. We found a signiﬁcant and strong associ-
ation between the frequency of chromosomal aberrations and cancer incidence in a group of
miners exposed to radon, where a 1% increase in frequency of chromosomal aberrations was fol-
lowed by a 64% increase in risk of cancer (p < 0.000). In contrast, the collected data are inadequate
for a critical evaluation of the association with exposure to other chemicals. Key words: cancer inci-
dence, chemical mutagens, chromosome aberrations, radon, risk. Environ Health Perspect
109:41–45 (2001). [Online 12 December 2000]
http://ehpnet1.niehs.nih.gov/docs/2001/109p41-45smerhovsky/abstract.htmlgasification in one gasworks. They were
examined January 1980–May 1992.
Polyaromatic hydrocarbons. Members of
the polyaromatic hydrocarbon (PAH) group
were workers who had been exposed to dif-
ferent PAHs generated mostly by burning
processes. They were examined April
1983–October 1990.
Nonexposed. The nonexposed matched
referent group is made up of a small group
of subjects who were examined January
1981–October 1998.
Other chemicals. The other chemicals
group includes individuals exposed to miscel-
laneous chemicals or mixtures of chemicals
for whom the numbers of participants were
too small to create meaningful strata. These
subjects were examined from July 1978 to
October 1998.
We retrieved data on 4,288 individuals
from laboratory records. Because of insuffi-
cient personal identification, 231 (5.39%)
were excluded. Furthermore, we did not
include 28 (0.65%) subjects with cancer onset
before the date of cytogenetic analysis and 56
(1.31%) subjects with < 100 metaphases
scored, leaving 3,973 (92.66%) subjects in
the study. All subjects were at least 17 years of
age at the date of cytogenetic analysis. Because
many of the subjects included in the study
were repeatedly examined for the frequency of
CAs, altogether 8,962 cytogenetic tests were
available for the epidemiologic analysis. Basic
descriptive characteristics of the cohort are
presented in Tables 1–3. 
Cytogenetic Analysis
The cytogenetic analysis of human PBLs fol-
lowed the same protocol in all participating
cytogenetic laboratories. We used the conven-
tional modiﬁed Hungerford method on short-
term cultures for 52 hr, with all cells being in
the first division. The peripheral blood was
collected by venipuncture in heparinized
tubes, and whole-blood cultures were estab-
lished from the collected blood within 24 hr.
Before culturing, we stored the tubes contain-
ing heparinized blood at 4–8°C. The cultures
were set up in RPMI 1640 medium supple-
mented with 20% calf serum and 1% phyto-
hemagglutinin. We added colchicin 2 hr
before harvesting. The cells were collected by
centrifugation, resuspended in a prewarmed
hypotonic solution (0.075 M KCl) for 20
min, and ﬁxed in acetic acid:methanol (1:3,
v:v). The slides were prepared by air drying
and stained with a 5% Giemsa solution (pH
6.8). Slides from each culture were randomly
numbered and scored “blind” in numerical
order. We examined at least 100 well-spread
metaphases with 46 ± 1 centromeres per
donor on coded slides (10,20). 
The National Reference Laboratory of
Genetic Toxicology of the National Institute
of Public Health, Prague, coordinated the
effort of all participating cytogenetic labora-
tories. The National Reference Laboratory
has been responsible for the standardization
(development of standard methods, supply
media, and training of new personnel) and
control (quality control of field laboratory
workers by assessing the cytogenetic analysis
results on coded slides, blood sampling and
handling, and preparation of cell cultures,
etc.). This method ensured the comparabil-
ity of cytogenetic analysis results of all labo-
ratories (10).
We evaluated the four categories of CAs:
chromatid and chromosome breaks and
chromatid and chromosome exchanges. Gaps
were not scored as aberrations. Cells bearing
breaks or exchanges were considered as
aberrant cells. We treated the frequency of
CAs enumerated as a percentage of aberrant
lymphocytes as continuous variable. To
account for possible differences in mecha-
nisms of inducing CAs in relation to the
type of exposure and for the sake of some
statistical procedures as well as comparability
of the results with previously published stud-
ies, the subjects were also categorized into
the terciles and/or quartiles. Cutoff points
are presented in Table 4 and may differ for
speciﬁc occupational exposure subgroups as
well as for the whole cohort. 
For subjects who had been examined for
CAs more than once, we used mean scores
for all computations. 
Cancer Incidence and Total
Mortality
We obtained the information on the inci-
dence of cancer and the speciﬁc mortality in
the cohort up to 31 March 1999 (the end of
the overall follow-up period) from the
National Oncological Registry maintained
by the Institute of Health Information and
Statistics of the Czech Republic. 
The critical point in the identiﬁcation of
the cancer cases in the Oncological Registry
is the knowledge of a birth number, which is
the unique personal identification in the
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Table 1. Distribution of the chromosomal aberrations.
No. of Percentiles of CA
Exposure subjects 10th 50th 90th
Radon 236 1.50 2.38 4.00
Radiography wards 73 1.00 2.00  5.00
BCME 244 1.23 2.66 4.67
Cytostatic drugs 1,297 0.67 2.00 4.00
Coal gasiﬁcation 217 1.00 2.00 4.00
PAHs 365 1.00 2.00 5.00
Referents 336 0.00 2.00 4.00
Other chemical substances 1,205 0.00 2.00 5.00
Total 3,973 1.00 2.00 4.25
Table 2. Distribution of sex, cases, and deaths. 
No. of  Percent Percent Cases Deathsa
Exposure subjects of  total male No. Percent No.  Percent
Radon 236 5.9 97.0 33 14.0 27 11.4
Radiography wards 73 1.8 30.1 3 4.1 0 0.0
BCME 244 6.1 87.7 12 4.9 9 3.7
Cytostatic drugs 1,297 32.6 16.6 13 1.0 3 0.2
Coal gasiﬁcation 217 5.5 87.6 16 7.4 10 4.6
PAHs 365 9.2 91.8 7 1.9 15 4.1
Referents 336 8.5 45.2 15 4.5 6 1.8
Other chemical substances 1,205 30.3 63.6 45 3.7 24 2.0
Total 3,973 100.0 53.4 144 3.6 94 2.4
aDeaths from causes other than cancer.
Table 3. Distribution of age at testing and the length of follow-up. 
No. of Age at testing (years) Follow-up (person-years) Total
Exposure subjects 10th 50th 90th 10th 50th 90th follow-up
Radon 236 29 38 54 9 17 22 3,792
Radiography wards 73 24 40 52 3 9 10 592
BCME 244 22 31 47 13 18 22 4,344
Cytostatic drugs 1,297 21 33 51 1 4 11 6,771
Coal gasiﬁcation 217 27 39 52 8 13 17 2,948
PAHs 365 24 38 50 9 12 15 4,267
Referents 336 22 36 51 1 10 15 2,960
Other chemical  1,205 25 38 53 2 10 16 12,101
substances
Total 3,973 22 36 52 1 9 17 37,775Czech Republic. In cases of uncertainty, we
checked the accuracy of the birth numbers
in records maintained by employers and
crosschecked the numbers in the Central
Registry of Inhabitants of the Czech Police.
The Central Registry of Inhabitants also
conﬁrmed the accuracy of mortality data.
Statistical Methods
We calculated the expected numbers of can-
cer cases, the standardized incidence ratios
(SIRs), and the 95% conﬁdence intervals for
SIRs on basis of the distribution of age- and
sex-speciﬁc rates within the cohort. We used
the Kaplan-Meier survival analysis to describe
the differences in total cancer incidence
during the follow-up period and plotted
Kaplan-Meier survival curves. We used Cox
regression (21) to model the associations
between cancer incidence, the CA frequency,
age at ﬁrst testing, and sex. For a dependent
time variable, we used either a) the time from
the ﬁrst test until the diagnosis of malignant
neoplasm or death for causes other than can-
cer or b) the end of the follow-up period. The
stratification on the types of occupational
exposure allowed for different shapes of
baseline hazard function in each occupational
exposure subgroup. Routine diagnostic tests
did not detect any substantial violation of
underlying assumptions of Cox regression. 
Results
At time of the analyses, there were data on
3,973 subjects, who contributed with
37,775 person-years to the total follow-up
time. All subjects were divided into eight
occupational groups by type of occupational
exposure. In the cohort, there were 144 cases
of cancer, shown in Table 5; 94 subjects
were censored because their deaths were not
caused by cancer. Of the participants, 53.4%
were male; however, the sex distribution was
not proportional. Males were overrepre-
sented in several occupational groups (expo-
sure to radon and PAHs), but females
represented a larger portion of the group
exposed to cytostatic drugs. The age distrib-
ution at the time of cytogenetic analysis and
at follow-up are presented in Table 3. In
spite of the fact that the subjects’ ages were
similar when the follow-up began (overall
median 36 years of age), the length of the
follow-up was significantly different. For
example, the medians of follow-up periods
in the radon and BCME groups were 17 and
18 years, respectively; in contrast, the
median follow-up period was only 4 years in
the cytostatic drug group. The distribution
of CA frequencies and cutoff points used to
classify study subjects into the specific CA
frequency groups are shown in Tables 1 and
4. The overall median CA frequency (2%)
was found in the cohort (10th percentile = <
1.00%, 90th percentile = < 4.25%).
Descriptive characteristics of the cohort are
presented in Tables 1–3. 
Differences in SIRs and in Kaplan-Meier
survival analyses did not indicate an associa-
tion between CA frequency and cancer
incidence in pooled data. Although the SIR
was elevated for high CA frequency (1.20;
95% CI, 0.94–1.52), the difference was not
statistically significant (p > 0.1). We found
no increase in the SIR (0.94; 95% CI,
0.67–1.28) in the medium CA frequency
group. There were also no statistically signiﬁ-
cant trends in SIR (p > 0.05). This is consis-
tent with the result of the Kaplan-Meier
survival analysis shown in Figure 1.
However, the more sophisticated Cox regres-
sion model, which accounted for the age at
the time of the test, sex, and the type of occu-
pational exposure, showed a statistically sig-
niﬁcant increase in the hazard ratio (HR) in
the high CA frequency group (1.6; 95% CI,
1.01–2.37; Table 6). 
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Table 4. Categorization of subjects according to chromosomal aberration frequency (%).
Tercile Quartile
1st 2nd 3rd 1st 2nd (lower  3rd (upper 4th
Exposure (low) (medium) (high) (low) intermediate) intermediate) (high)
Radon < 2.00 2.00– < 2.88 ≥ 2.88 < 1.87 1.87– < 2.38 2.38– < 3.00 ≥ 3.00
Radiography wards < 2.00 2.00– < 3.00 ≥ 3.00 – – – –
BCME < 2.10 2.10– < 3.11 ≥ 3.11 – – – –
Cytostatic drugs < 1.50 1.50– < 2.50 ≥ 2.50 – – – –
Coal gasiﬁcation < 1.78 1.78– < 2.57 ≥ 2.57 – – – –
PAHs < 2.00 2.00– < 3.00 ≥ 3.00 – – – –
Referents < 1.00  1.00– < 3.00 ≥ 3.00 – – – –
Other chemical substances < 2.00 2.00– < 3.00 ≥ 3.00 – – – –
Chemicals – – – < 1.00 1.00– < 2.00 2.00– < 3.00 ≥ 3.00
Total < 1.89 1.89– < 2.99 ≥ 3.00 – – – –
Table 5. Classiﬁcation of neoplasms according to International Classiﬁcation of Diseases, Revision 10 (ICD-10).
Occupational exposure
Radiography Cytostatic Coal Other
ICD-10 code Radon wards BCME drugs gasiﬁcation PAHs Referents chemicals Total
00–14 Lip, oral cavity, and pharynx 1 – – 1 – 2 1 – 5
15–26 Digestive organs 6 – 4 1 3 1 2 8 25
30–39 Respiratory and intrathoracic organs 18 – 1 – 5 1 3 7 35
40–43 Skin 3 1 2 2 3 1 3 11 26
45–49 Mesothelium and soft tissue – – 1 1 – – – – 2
50 Breast – 1 – 2 – – – 2 5
51–58 Female genital organs – – – 4 1 1 3 4 13
60–63 Male genital organs 1 – 2 – – – – 4 7
64–68 Urinary tract  2 1 2 1 3 1 1 3 14
69–72 Eye, brain, and other parts of CNS 1 – – – – – 1 1 3
73–75 Thyroid and other endocrine glands – – – – – – – 2 2
76–80 Malignant neoplasms of ill-deﬁned,  – – – – 1 – – – 1
secondary, and unspeciﬁed sites
91–96 Lymphoid, hematopoietic, and related 1 – – 1 – – 1 3 6
tissue
Total 33 3 12 13 16 7 15 45 144
CNS, central nervous system. The stratiﬁcation of the data on occupa-
tional exposures brought more insight into
the nature of the association between CA fre-
quency and cancer incidence. We constructed
Kaplan-Meier survival curves for each occupa-
tional group; there was an apparent associa-
tion between CA frequency and total cancer
incidence in the group of miners exposed to
radon (Figure 2). In the other occupational
groups, we found no similar pattern of an
association between CA in PBL and cancer.
Therefore, only the results of the Kaplan-
Meier survival analysis of combined groups
that included only subjects with a history of
chemical exposure and referents is shown in
Figure 3. 
This finding was confirmed in models
with several explanatory variables. Two Cox
regression models of the association between
CA frequency and total cancer incidence in
the radon-exposed group are presented in
Table 7. When we allocated the radon-
exposed subjects into the CA frequency
groups according to quartiles, there was a
statistically significant excess in HR in the
high CA frequency group (8.0; 95% CI,
2.42–26.13). Moreover, an increase in CA
frequency was followed by an increase in the
HR. If the model was simpliﬁed using a con-
tinuous term describing CA frequency instead
of the dummy variables, the association
between CA frequency and total cancer inci-
dence remained statistically signiﬁcant. 
No statistically signiﬁcant differences were
detected in HR in the other occupational
groups. Table 8 shows the results of Cox
regression analysis performed on the com-
bined group of subjects exposed to chemicals
or chemical mixtures and referents. Attempts
to detect an association between CA fre-
quency and a speciﬁc group of cancers failed.
Discussion
Cytogenetic analysis has been successfully
used in occupational medicine for decades.
On many occasions, it has been shown to be
an effective tool to identify occupational
exposures to mutagens and carcinogens.
Nevertheless, at a time when the PBL CAs
and other cytogenetic end points were con-
ceptualized as biomarkers of early effects in
the process of carcinogenesis, there was no
empirical evidence of an association between
cancer incidence and CAs. Until recently,
few epidemiologic studies addressed that
issue. The present study was designed to test
the validity of CAs as the biomarker of early
effect and as a predictive value for a subse-
quent risk of cancer.
In the present study, there has been
improvement over previous methods. First of
all, in spite of the fact that the study includes
subjects examined for CAs in four laborato-
ries, the interlaboratory differences in the
scoring of CAs have not been signiﬁcant. The
quality of performance of the cytogenetic lab-
oratories was under the quality control
program of the National Institute of Public
Health in Prague since their establishment;
this originally included a uniform laboratory
protocol and classiﬁcation and scorers’ train-
ing. In the early 1980s, the quality control
program gradually developed into a quality
assurance/quality control system, which
includes regular testing of reference samples
(10). Second, the information on the occu-
pational exposures of all subjects in the study
was available. Finally, the study is based on
the largest population examined systemati-
cally for CAs (3,973 subjects who underwent
8,962 cytogenetic analyses). 
The data analysis revealed strong associa-
tions between CA frequency and total cancer
incidence in the group of underground min-
ers exposed to radon. The validity of this
ﬁnding is supported by the fact that, in that
particular case, all subjects were examined
for CA frequency in the same laboratory by
the same personnel; therefore, interlabora-
tory bias could not affect this result. Also,
the potential for other bias, such as selection
or information bias, is very limited. All eligi-
ble workers were included in the study, and
cytogenetic assays had been performed
repeatedly in all miners. (It is important to
note that all subjects in this subgroup
worked in the same ore mine.)
In contrast, we could not demonstrate
any association between CAs and cancer in
cases of other occupational exposures. If we
exclude interlaboratory bias as an explana-
tion for this finding, there are still other
alternatives. The most probable explanation
is that the most numerous subgroups in the
study were relatively young and the length of
follow-up has been too short to experience a
sufﬁcient number of cases. In contrast, in the
occupational subgroups where the follow-up
period is sufﬁciently long, there are few par-
ticipants. Also, confounding bias could have
masked the association. Heterogeneity
caused by random factors is very likely to be
substantial, decreasing the study power. In
the Cox regression model, we have been able
to account only for age at testing, sex, and
the type of occupational exposure. Data on
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Figure 1. Kaplan-Meier survival analysis for the
whole cohort (p = 0.177). 
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Table 6. Cox regression analyses for the whole cohort.
95% CI for HR
Variable HR Signiﬁcance Lower Upper
CA frequency  0.079
Low 1.0 – – –
Medium 1.1 0.679 0.69 1.76
High 1.6 0.044 1.01 2.37
Age at testing (years) 1.1 0.000 1.07 1.10
Sex (1 for female) 0.8 0.321 0.50 1.25
Overall signiﬁcance 0.000
The model was adjusted for the type of occupational exposure.
Figure 2. Kaplan-Meier survival analysis for the
radon exposed group (p = 0.011).
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Figure 3. Kaplan-Meier survival analysis for the
workers exposed to chemicals (p = 0.60).
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factors, such as the length and intensity of
occupational exposures, diet or smoking, was
not available at the time of analyses.
The predictive value of a spot test on CAs
is low. When we used predictor spot tests (the
outcome of the ﬁrst CA assay or the outcome
of the highest CA assay observed in partici-
pant) in Cox regression models, the associa-
tion between CA frequency and cancer
incidence vanished even in the radon-exposed
group. This is consistent with the early ﬁnd-
ings of high intraindividual variability in CA
frequencies. Consequently, because the sub-
groups exposed to chemicals were not system-
atically examined and because the frequency
of CAs per capita is much lower than in the
radon-exposed group, it may be difficult to
detect an association between CA frequency
and cancer. 
The frequency of CAs in PBLs is a surro-
gate measure of events, which may occur in
other tissues. It is plausible to expect that
changes in speciﬁc tissues are reﬂected in PBLs
with a different intensity. Consequently, the
association between CA frequency and speciﬁc
cancers may be assumed to vary (11,12).
However, we failed to demonstrate such
speciﬁc association, probably because of the
low number of different types of malignan-
cies under scrutiny (Table 5). 
In conclusion, the present study has
been, to a certain degree, consistent with pre-
vious observations. Also, this study has
shown evidence that supports the association
between CA frequency in PBLs and cancer
incidence. However, more subjects are
needed before analyses and conclusions can
be completed. The study should be able to
provide more information on the relationship
between CAs and cancer after a substantial
increase in the number of individuals in the
study and a somewhat longer follow-up time.
Furthermore, we have made an effort to col-
lect additional data on potentially modifying
factors and confounders such as smoking and
the length of occupational exposures. We are
interested in testing the independence of pre-
dictivity of CAs on radiation dose and ciga-
rette smoking in the group of miners exposed
to radon.
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Table 7. Cox regression analyses for radon-exposed miners.
95% CI for HR
Model Variable HR Signiﬁcance Lower Upper
Categorized CA frequency Frequency of CA (%) 0.027
Low 1.0 – – –
Lower intermediate 2.8 0.125 0.75 10.23
Upper intermediate 3.0 0.090 0.84 10.95
High 8.0 0.001 2.42 26.13
Age at testing (years) 1.1 0.000 1.07 1.15
Overall signiﬁcance 0.000
Continuous CA frequency Frequency of CA (%) 1.64 0.000 1.38 1.94
Age at testing (years) 1.10 0.000 1.07 1.14
Overall signiﬁcance 0.000
Table 8. Cox regression analyses for individuals exposed to chemical substances and referents. 
95% CI for HR
Model Variable HR Signiﬁcance Lower Upper
Categorized CA frequency Frequency of CA (%) 0.852
Low 1.0 – – –
Lower intermediate 1.0 0.992 0.53 1.92
Upper intermediate 0.8 0.566 0.41 1.62
High 1.0 0.905 0.53 2.04
Age at testing (years) 1.1 0.000 1.06 1.10
Sex (1 for female) 0.9 0.835 0.54 1.65
Overall signiﬁcance 0.000
Continuous CA frequency
Frequency of CA (%) 0.96 0.602 0.84 1.11
Age at testing (years) 1.08 0.000 1.06 1.10
Sex (1 for female) 0.94 0.815 0.54 1.63
Overall signiﬁcance 0.000
Models were adjusted for the type of occupational exposure.